| oxaliplatin / Generic mfg. |
NCT00222469: Combination Chemotherapy for 1st Line Treatment of Advanced or Metastatic Pancreatic Cancer |
|
|
| Completed | 2 | 50 | US | bevacizumab, gemcitabine, oxaliplatin | University of Oklahoma, Genentech, Inc., Sanofi, M.D. Anderson Cancer Center | Metastatic Pancreatic Cancer | 05/07 | 05/07 | | |
NCT02195180 / 2013-004262-34: Efficacy and Safety of L-asparaginase Encapsulated in RBC Combined With Gemcitabine or FOLFOX in 2nd Line for Progressive Metastatic Pancreatic Carcinoma |
|
|
| Completed | 2 | 141 | Europe | ERY001, L asparaginase encapsulated in erythrocytes, Gemcitabine, 5-fluoro-uracil/oxaliplatin/leucovorin (folfox) | ERYtech Pharma | Pancreatic Adenocarcinoma Metastatic | 02/17 | 11/17 | | |
NCT00242190: Gemcitabine, Oxaliplatin and Radiation Therapy in Pancreatic Cancer |
|
|
| Completed | 1/2 | 40 | US | oxaliplatin, gemcitabine, radiation therapy | University of Michigan Rogel Cancer Center, Sanofi-Synthelabo | Pancreatic Neoplasms | 03/06 | 02/10 | | |
| Completed | 1/2 | 46 | Europe | gemcitabine, oxaliplatin, capecitabine | University Hospital, Basel, Switzerland, Swiss National Science Foundation, Swiss Cancer League, Roche Pharma AG, Sanofi | Locally Advanced Pancreatic Cancer, Metastatic Pancreatic Cancer | 02/09 | 12/09 | | |
|
|
NCT00463840: Chemoradiation With Oxaliplatin and Fluorouracil (5FU) for Locally Advanced Pancreatic Cancer |
|
|
| Terminated | 1/2 | 24 | US | Oxaliplatin, Oxaliplatin: Eloxatin, 5FU, 5-Fluorouracil, Radiation, Surgery, FOLFOX 6 | NYU Langone Health, Sanofi | Pancreatic Cancer | 07/10 | 10/15 | | |
